Circulating fibroblast activation protein α is reduced in acute ischemic stroke
BackgroundFibroblast activation protein α (FAP), a membrane glycoprotein with dipeptidyl-peptidase and collagenase properties, is expressed in atherosclerotic plaques and remodeling of the extracellular matrix based on fibrosis. Fibrosis is a main contributor of atrial cardiomyopathies. In acute MI,...
Main Authors: | Jan-Thorben Sieweke, Gerrit M. Grosse, Karin Weissenborn, Anselm A. Derda, Saskia Biber, Johann Bauersachs, Udo Bavendiek, Jochen Tillmanns |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1064157/full |
Similar Items
-
miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
by: Jan-Thorben Sieweke, et al.
Published: (2020-04-01) -
Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases
by: Yan Cui, et al.
Published: (2023-09-01) -
Radioligands Targeting Fibroblast Activation Protein (FAP)
by: Thomas Lindner, et al.
Published: (2021-11-01) -
Design, Synthesis and Preclinical Assessment of <sup>99m</sup>Tc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging
by: Diana Trujillo-Benítez, et al.
Published: (2022-01-01) -
Selection and Identification of an ssDNA Aptamer for Fibroblast Activation Protein
by: Xiaomin Zhang, et al.
Published: (2023-02-01)